USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/9032
Title: Cystic fibrosis (mucoviscidosis) in children
Authors: Şciuca, S.
Keywords: cystic fibrosis;children;etiology;clinical features;complications;management
Issue Date: 2012
Publisher: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”
Citation: ŞCIUCA, S. Cystic fibrosis (mucoviscidosis) in children. In: Curierul Medical. 2012, nr. 3(327), p. 400. ISSN 1875-0666.
Abstract: Cystic fibrosis (CF) is a monogenic autosomal recessive disorder with a chronic progressive evolution, which determines an abnormal production of viscous secretions from the glands of exogenous excretion, and characterized by chronic obstructive pneumopathy, chronic diarrhea, malnutrition and malabsorption syndromes. Respiratory symptoms onset in CF patients usually starts early – 80% in the first year of life with recurrent bronchitis, mostly with severe obstructive syndrome, latent persistent pneumonias, pulmonary and non-respiratory complications development. CF is also characterized by the installation of chronic obstructive pulmonary disease, which manifests itself by wheezing, prolonged expiration, persistent cough during respiratory infectious episodes which has latent evolution, nocturnal exacerbations, paroxysmal and exhausting evolution. Bronhoobstructive syndrome is develops al the level of the small bronchi and is conditioned by the viscous, sticky secretions and infective bacterial component. Expectorated secretions are abundant, purulent, in cases with progressive evolution haemoptysis may develop. In long-term evolution children develop progressive respiratory failure. The progressive evolution of the disease is conditioned also by resistant bacterial agents (S.aureus, Ps aerugenosae, H. influenzae), which accelerates destructive processes of the lung parenchyma and contribute to the expansion of the pulmonary fibrosis phenomena, and development of complications in the lungs (pneumothorax, atelectasis, bronchiectasis, bullous-distrophy, lung abscess, haemoptysis, asphyxia, calcinates in lungs, pulmonary hypertension and pulmonary heart disease). Chest deformity is a clinical expression of the severe pulmonary pathological process: thoracic cage expansion, dorsal kyphosis, hypertrophic pulmonary osteoarthropathy (in schoolage children) which causes chest pain, bone brittleness (fragility), swelling, and hydrarthrosis. Chronic persistent severe hypoxia determines the presence in CF children of fingers hippocratism. ENT disorders at children with CF are presented by the nasal polyposis, sinusitis and chronic rhinitis, transmission deafness. The prognosis is reserved, with high risks of death in cases with severe neonatal onset. Currently the disease may have a stable evolution, if favorable circumstances are present: early diagnosis, efficient treatment with digestive enzymes, control of pulmonary infections, respiratory kinesiotherapy.
metadata.dc.relation.ispartof: Curierul Medical: Congresul III al Medicilor de Familie din Republica Moldova, 17–18 mai, 2012, Chişinău, Republica Moldova, Conferinţa Naţională „Maladii bronhoobstructive la copii”, consacrată profesorului universitar, doctor habilitat Victor Gheţeul, 27 aprilie, Chişinău, Republica Moldova
URI: http://moldmedjournal.md/wp-content/uploads/2016/09/18.pdf
http://repository.usmf.md/handle/20.500.12710/9032
ISSN: 1875-0666
Appears in Collections:Curierul Medical, 2012, Vol. 327, Nr. 3

Files in This Item:
File Description SizeFormat 
Cystic_fibrosis_mucoviscidosis_in_children.pdf115.33 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback